Lactate-induced Autophagy Activation: Unraveling the Therapeutic Impact of High-intensity Interval Training on Insulin Resistance in Type 2 Diabetic Rats
Authors
Affiliations
Impaired autophagy is a hallmark of diabetes. The current study proposed to investigate if high intensity interval training (HIIT) induced lactate accumulation could stimulate autophagy in type 2 diabetic male rats. 28 male Wistar rats were randomly assigned into four groups: Healthy Control (CO), Diabetes Control (T2D), Exercise (EX), and Diabetes + Exercise (T2D + EX). Diabetes was induced by feeding high-fat diet and administrating single dose of streptozotocin (35 mg/kg). After becoming diabetic, the animals in the exercise groups (EX and T2D + EX) performed an eight-week HIIT (4-10 interval, 80-100% Vmax, 5 days per week). Serum levels of lactate, glucose and insulin as well as the levels of lactate, pyruvate, lactate transporter monocarboxylate transporter 1 (MCT1), phosphorylated mitogen-activated protein kinases (p-MAP 1 and 2), phosphorylated extracellular signal-regulated protein kinases 1 and 2 (p-ERK 1 and 2), mammalian target of rapamycin (p-mTOR), ribosomal protein S6 kinase beta-1 (p-70S6k), p90 ribosomal S6 kinases (p-90RSK), autophagy related 7 (ATG7), Beclin-1, microtubule-associated protein 1A/1B, and 2A/2B -light chain 3 levels (LC3-I), (LC3- II), (LC3I/LC3II) in soleus muscle were measured. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and serum glucose was lower in T2D + EX compared to T2D group (P < 0.0001). While serum and soleus muscle levels of lactate was not different between T2D and T2D + Ex, the levels of Pyruvate (P < 0.01), MCT1, p-ERK1/2, p-mTOR, p70S6k, P-90RSK, ATG7, LC3-II, and LC3-II/LC3I ratios were higher in T2D + EX compared to T2D group (P < 0.0001). We concluded that eight weeks of high-intensity interval training could activated ERK/P90SRK while inhibiting mTOR/P70S6K signaling pathway in lactate dependent manner. It means increased autophagy which resulted in improve insulin resistance (IR) and reduce blood glucose.
Cheng L, Chang S, Tan Y, He B Regen Ther. 2024; 28:81-89.
PMID: 39703816 PMC: 11655694. DOI: 10.1016/j.reth.2024.11.013.
Khosravi P, Shahidi F, Eskandari A, Khoramipour K Iran J Basic Med Sci. 2024; 27(11):1430-1439.
PMID: 39386233 PMC: 11459343. DOI: 10.22038/ijbms.2024.77038.16664.
Khoramipour K, Rajizadeh M, Akbari Z, Arjmand M Heliyon. 2024; 10(15):e34917.
PMID: 39170342 PMC: 11336285. DOI: 10.1016/j.heliyon.2024.e34917.
Khoramipour K, Rezaei M, Moslemizadeh A, Hosseini M, Ebrahimnezhad N, Bashiri H Behav Brain Funct. 2024; 20(1):9.
PMID: 38702776 PMC: 11067136. DOI: 10.1186/s12993-024-00235-0.
Joukar S, Rajizadeh M, Bejeshk M, Alavi S, Bagheri F, Rami M Sci Rep. 2024; 14(1):7113.
PMID: 38532054 PMC: 10965991. DOI: 10.1038/s41598-024-57818-0.